|
Investigational drug MLN0128, a novel TORC1/2 inhibitor, demonstrates potent oral antitumor activity in human breast cancer xenograft models |
|
|
|
Title: |
Investigational drug MLN0128, a novel TORC1/2 inhibitor, demonstrates potent oral antitumor activity in human breast cancer xenograft models |
Author: |
Gökmen-Polar, Yesim Liu, Yi Toroni, Rachel A. Sanders, Kerry L. Mehta, Rutika Badve, Sunil Rommel, Christian Sledge, George W. |
Appeared in: |
Breast cancer research and treatment |
Paging: |
Volume 136 (2012) nr. 3 pages 673-682 |
Year: |
2012 |
Contents: |
|
Publisher: |
Springer US, Boston |
Source file: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|